Grab latest SOCRA CCRP Dumps as PDF Updated on 2026 [Q43-Q57]


0
Categories : CCRP , SOCRA
Rate this post

Grab latest SOCRA CCRP Dumps as PDF Updated on 2026

Newly Released CCRP Dumps for Clinical Research Professional Certified

SOCRA CCRP Exam Syllabus Topics:

Topic Details
Topic 1
  • Research Study Closure: This section of the exam measures the skills of Clinical Research Coordinators and covers the activities required to properly conclude a clinical trial. It involves participating in the study closeout visit to verify documentation and account for the investigational product. The domain also includes developing and submitting final closure reports to the IRB, study sponsor, regulatory authorities, and clinicaltrials.gov. Finally, it covers the procedures for archiving study records.
Topic 2
  • Research Study Start-Up: This section of the exam measures the skills of Clinical Research Coordinators and covers the initial planning and setup of a clinical trial. It involves coordinating the development of the study protocol, ensuring it considers ethical guidelines and regulatory pathways like IND or IDE. It also includes creating essential study documents like informed consent forms and case report forms. The domain covers obtaining necessary approvals from stakeholders like the IRB and sponsor, selecting study sites, training staff, and ensuring the study’s compliance with various laws. Additionally, it involves obtaining the research product and preparing all necessary tools and documentation for the study’s commencement.|Research Study Implementation: This section of the exam measures the skills of Clinical Research Associates and covers the active management and execution of the clinical trial. It focuses on following the study protocol and standard operating procedures, managing the investigational product, and ensuring ongoing regulatory compliance. The domain includes identifying, documenting, and reporting any study anomalies such as adverse events or protocol deviations. It also involves managing subject recruitment, consent, and retention, as well as maintaining all study records and essential documents. Furthermore, it covers communicating with all study stakeholders and participating in study audits to ensure quality and adherence to regulations.

 

NEW QUESTION 43
According to ICH GCP, an electronic data capture (EDC) system must:

 
 
 
 

NEW QUESTION 44
What is included in the Statement of Investigator (Form FDA 1572)?

 
 
 
 

NEW QUESTION 45
An investigator discovered a new serious unanticipated adverse device effect. Who must they notify?

 
 
 
 

NEW QUESTION 46
According to 21 CFR Part 11, each electronic signature must be unique and:

 
 
 
 

NEW QUESTION 47
A sponsor received a report from an investigator regarding the investigator’s use of an investigational device without having obtained informed consent. The sponsor must submit a copy of the report to the FDA within:

 
 
 
 

NEW QUESTION 48
In accordance with 45 CFR 46, in addition to the Office for Human Research Protections (OHRP), a suspension of IRB/IEC approval must be reported to which of the following?

 
 
 
 

NEW QUESTION 49
A subject has creatinine 1.6 mg/dL, slightly above eligibility (#1.5). Investigator believes this is normal for size. When can subject be enrolled?

 
 
 
 

NEW QUESTION 50
Which case history documents must be at both sponsor and site?

 
 
 
 

NEW QUESTION 51
The study coordinator for a new Phase III vaccine study is preparing documents for IRB/IEC submission.
According to the ICH GCP Guidelines, which of the following documents should be included in the submission?

 
 
 
 

NEW QUESTION 52
In accordance with the CFR, for at least how many years after the completion of a study must the clinical investigator provide the sponsor with relevant changes to financial information?

 
 
 
 

NEW QUESTION 53
An investigator reports a serious adverse event suspected to be drug-related. By CFR, the sponsor must notify FDA no later than:

 
 
 
 

NEW QUESTION 54
Which of the following identifies content that should be included in a clinical research protocol?

 
 
 
 

NEW QUESTION 55
In an IND study, the specified dosage of an investigational product is 2 mg twice a day for 10 days. The product is available in 1 mg tablets. The subject was given 45 tablets and was instructed to take 2 mg of the product twice a day for 10 days. How many tablets should the subject have after the 10 days?

 
 
 
 

NEW QUESTION 56
A Phase I clinical trial is initiating. Who is responsible for ensuring that site staff are adequately informed about trial duties?

 
 
 
 

NEW QUESTION 57
When can an IRB/IEC review a study using expedited review?

 
 
 
 

Latest CCRP Exam Dumps SOCRA Exam from Training: https://www.vceprep.com/CCRP-latest-vce-prep.html

         

Related Links: myportal.utt.edu.tt myportal.utt.edu.tt myportal.utt.edu.tt myportal.utt.edu.tt www.stes.tyc.edu.tw www.stes.tyc.edu.tw

Leave a Reply

Your email address will not be published. Required fields are marked *

Enter the text from the image below
 

DMCA Privacy Policy Contact US

© 2022 Latest Exam Prep.